Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) is one of the most highly responsive interferon-stimulated genes, but its biological functions are poorly understood. In this study, we aimed to explore the underlying mechanisms by which depleting IFIT2 induces the migration of oral squamous cell carcinoma (OSCC) cells. Stable IFIT2-depleted cells underwent epithelial-mesenchymal transition (EMT) and exhibited enhanced cell motility and invasiveness compared with control cells. Furthermore, our results indicated that atypical protein kinase C (aPKC) was activated in IFIT2-depleted cells. Inhibition of aPKC using a specific myristoylated PKCz pseudosubstrate or aPKC-targeting small interfering RNA (siRNA) abolished IFIT2 depletioninduced EMT, migration and invasion, indicating that the activation of aPKC has an essential role in regulating the cellular responses induced by IFIT2 depletion. Following tail-vein injection, IFIT2-depleted OSCC cells colonized not only the lungs but also the heart, head and neck, retroperitoneal, and peritoneal cavities; whereas control cells predominantly localized in the lungs. IFIT2 mRNA and protein expression was positively associated with E-cadherin expression in OSCC patient specimens. The loss of E-cadherin and IFIT2 expression was observed at the invasive front of OSCC tumors, suggesting that the loss of IFIT2 may induce EMT and lead to the metastasis of OSCCs. OSCC patients possessing reduced IFIT2-expression levels (IFIT2 o50%) exhibited greater rates of distant metastasis and poor prognoses compared with OSCC patients who expressed greater levels of IFIT2 (IFIT2 X50%). These results demonstrate that IFIT2 depletion activates the aPKC pathway and consequently induces EMT, cell migration and invasion. Most importantly, depleting IFIT2 may participate in OSCC tumor progression, particularly during metastasis. Taken together, our study demonstrates that IFIT2, a protein responsible for interferon stimulation, may prevent OSCC metastasis and serve as a valuable prognostic marker.
INTRODUCTION
Oral cancer is the eighth most common malignancy worldwide, and its incidence varies by geographic region. 1 In Taiwan, the incidence of oral cancer has been on the rise during the past several years, and male oral cancer patients have the fourth highest cancer mortality rate. 2 Patients with oral squamous cell carcinoma (OSCC) are clinically treated with surgery and/or radiation therapy and chemotherapy. 3 Additionally, OSCC patients exhibit a high incidence of lymph node metastases. 4 The appearance of a locoregional recurrence or a second primary tumor is the major prognosticators associated with the death of OSCC patients. [5] [6] [7] Distant metastases, which commonly occur in the lung, liver and bone, are critical clinical features associated with treatment failure. 8, 9 Thus, the overall 5-year survival rate for OSCC patients remains at 50% and has not significant improved during the last three decades. 10, 11 The frequency of metastasis is strongly associated with the migration potential of primary tumor cells. 12, 13 A number of molecules, including integrins, growth factors, adhesion molecules, cytokines, matrix-degrading proteases and Rho GTPases, have been shown to govern the migratory behavior of cells. 12, 14 Additionally, numerous studies have shown that epithelial-mesenchymal transition (EMT), an essential process controlling morphogenesis in multicellular organisms, 13 is required for migration and invasion in a variety of diseases, including fibrosis and cancer. [15] [16] [17] EMT is also a crucial event during the progression of OSCC. 18 Preventing and eliminating cancer metastasis remains a major challenge in oral cancer therapy. Thus, it is essential for examining the key mediators involved in OSCC metastasis.
Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), an interferon-stimulated gene family member, was cloned and sequenced in 1986 and has been demonstrated to be one of the most responsive interferon-stimulated genes to interferons, viruses and a variety of other agents in both human and rodent cell lines. 19 However, knowledge of IFIT2's biological functions and its effects on cancer development is relatively limited. Previous reports have demonstrated that IFIT2 interacts with a variety of molecules, including eIF3, which inhibits translation. 20 IFIT2 can also bind to b-tubulin and associate with mitotic spindles. 21 Our recent study revealed that IFIT2 interacts with the protein cytokeratin 18. 22 In cultured cells, we established an inverse correlation between IFIT2 expression and cell migration. This evidence suggests that IFIT2 may associate with cytoskeletal proteins, which have crucial roles in cell motility. Furthermore, our clinical observations, which indicate that decreased IFIT2 expression in OSCC tissues is associated with a significantly higher risk of lymph node metastasis and a worse prognosis in OSCC patients, 22 support the hypothesis that IFIT2 depletion augments cell migration and metastasis. However, the mechanisms by which IFIT2 attenuates cell migration and metastasis in OSCC remain unknown.
IFIT2 is a potential prognostic marker for OSCC patients with metastases. Therefore, we attempted to further characterize the signaling pathways involved in IFIT2 depletion-induced cell migration. Herein, we present results demonstrating that IFIT2 depletion activates atypical protein kinase C (aPKC) signaling and subsequently enhances cell migration and invasion. We also show that, following tail vein injection into mice, IFIT2-depleted OSCC cells form tumors in the thoracic, peritoneal and retroperitoneal cavities.
RESULTS

IFIT2 depletion enhances the EMT-like phenotype
To delineate the mechanisms by which IFIT2 regulates cell migration/invasion, two stable IFIT2-depleted CAL 27 clones (sh-IFIT2-1 and sh-IFIT2-2) were established using lentiviral transduction. IFIT2 mRNA and protein levels were significantly decreased in the two stable IFIT2-depleted clones compared with the sh-control cells, as determined by quantitative real-time PCR (Q-PCR) and western blot analysis (Figure 1a) . Furthermore, examining green fluorescence indicated that the two stable IFIT2-depleted clones lost their polygonal epithelial morphology and became dispersed and fibroblast-like in appearance (similar to a mesenchymal cell phenotype) (Figure 1b ). In the IFIT2-depleted cells, F-actin was detected using rhodamine phalloidin and revealed loose cell-cell contacts and the presence of filopodia at the cell periphery (Figure 1b) . To further examine the EMT-like phenotype of the IFIT2-depleted cells, the expression levels of epithelial and mesenchymal markers, including E-cadherin, N-cadherin, fibronectin and vimentin, were examined by Q-PCR and/or western blot. As shown in Figures 1c and d , the mRNA and protein expression levels of the epithelial marker E-cadherin were significantly reduced in the IFIT2-depleted cells compared with the sh-control cells. Immunofluoresence microscopy confirmed the decreased expression of E-cadherin by the IFIT2-depleted cells (Figure 1e ). Cytokeratin 18 expression, another epithelial differentiation marker, was also decreased in the IFIT2-depleted clones (Figure 1d ). The mRNA-and protein-expression levels of the mesenchymal marker fibronectin were remarkably enhanced in the IFIT2-depleted clones (Figures 1c and d) . Another mesenchymal marker, N-cadherin, had similar mRNA-expression levels in cells with and without IFIT2 depletion, but N-cadherin protein expression was significantly enhanced in the IFIT2-depleted clones (Figures 1c and d) . In addition, the expression of vimentin, a mesenchymal marker, was enhanced in the IFIT2-depleted clones (Figure 1d ). Similar to our observations of IFIT2-depleted CAL 27 cells, the knock-down of IFIT2 expression in other OSCC cell lines, including SCC25 and SCC4 cells, reduced E-cadherin protein expression and enhanced vimentin protein expression (Supplementary Figure S1) . Furthermore, the mRNA-expression levels of several transcription factors (Snail, ZEB1, ZEB2 and Twist1) that regulate the initiation of EMT 16 were assessed by Q-PCR in OSCC cells in the presence or absence of IFIT2. The effect of IFIT2 depletion on ZEB2 and Snail mRNA expression was inconsistent between the sh-IFIT2-1 and sh-IFIT2-2 cells (Figure 1f ). IFIT2 depletion had no effect on Twist1 mRNA expression (Figure 1f ).
However, ZEB1 mRNA levels were significantly increased in both of the IFIT2-depleted clones compared with the control cells ( Figure 1f ). As ZEB1 is a known suppressor of E-cadherin, 23 this result suggested that IFIT2 depletion leads to the activation of EMT signaling in cultured OSCC cells.
IFIT2 depletion enhances cell migration and invasiveness EMT is commonly associated with increased migration. 24 Therefore, we examined the effect of IFIT2 depletion on cell migration using the wound-healing assay. The sh-control cells achieved approximately 60% of wound closure 24 h after the wound was generated, whereas greater than 90% of the wound area was closed in the sh-IFIT2-2 cells after the same time period. The sh-IFIT2-1 cells also exhibited an enhanced ability to migrate (Figure 2a) . Intriguingly, the rhodamine phalloidin staining of F-actin revealed that the sh-control cells migrated with a cohesive pattern along the wound edge, whereas the sh-IFIT2-2 cells migrated with a pattern of loose contact and appeared flattened and spread out at the wound edge (Figure 2b) . Moreover, although E-cadherin was detected along the migrating edge of the sh-IFIT2-2 cells, the staining appeared weaker than that of the sh-control cells (Figure 2b) . A similar migration pattern was also observed in the sh-IFIT2-1 cells (data not shown). In addition to confirming the enhanced migratory activity of IFIT2-silenced cells, we performed transwell invasion assays using the modified Boyden chamber system. As shown in Figure 2c , the sh-IFIT2-1 and sh-IFIT2-2 cells exhibited a 4.8-fold and 9.3-fold increase in cell invasion, respectively, compared with the sh-control cells.
IFIT2 depletion activates aPKC signaling A variety of signal transduction pathways that participate in the regulation of cell migration/invasion concomitantly inhibit tumor progression. 16 To identify the regulatory pathways that contribute to the enhanced migration observed in IFIT2-depleted cells, we examined the effects of several inhibitors that target various signaling pathways on the migratory activity of sh-control and sh-IFIT2-2 cells. Using the wound-healing assay, we determined that the inhibition of PI3K, AKT, JNK and MEK1/2 reduced the migration of the sh-control and sh-IFIT2-2 cells to a similar degree, suggesting that the enhanced migration of the IFIT2-depleted cells was unlikely to be mediated by the activation of the PI3K/AKT, JNK or MEK1/2 signaling pathways (Supplementary Figure S2) . Next, we examined the effect of PKC inhibition on cell migration in the presence or absence of IFIT2. Gö 6976 and Gö 6983, which are inhibitors of classical and novel PKC activity, respectively, suppressed cell migration to a similar degree in both the sh-control and sh-IFIT2-2 cells (Figures 3a and b) . Intriguingly, the myristoylated PKCz pseudo-substrate significantly suppressed the migration of the sh-IFIT2-2 cells but had no effect on the sh-control cells (Figure 3c ). Consistent with the observed effects on migration, the phosphorylation of PKCa/b and PKCd/y was similar between the sh-control and sh-IFIT2-2 cells, whereas the phosphorylation of PKCz/i was significantly increased in the sh-IFIT2-2 cells compared with the sh-control cells (Figure 3d ). PKCz/i, members of the aPKC family, are activated through the interaction of their Phox/Bem 1 domain with the partitioning defective 6 (PAR6)-CDC42 complex, and this occurs independent of calcium and diacylglycerol. 25 Although we did not observe a significant change in the level of Rac1-GTP (Figure 3e) , our results revealed a significant increase in CDC42-GTP (Figure 3e ) and the phosphorylation of GSK3b (Ser 9 ) (Figure 3f ), which occurs downstream of CDC42-GTP, in both the sh-IFIT2-1 and sh-IFIT2-2 cells. These results suggest that aPKC signaling was activated in the IFIT2-depleted cells. aPKC suppression abolishes IFIT2 depletion-induced EMT, migration and invasion aPKCs have pleiotropic roles in cell migration, polarity and adhesion. 26 To confirm the participation of aPKC in regulating migration, invasion and EMT in IFIT2-depleted cells, we silenced the expression of PKCz or PKCi in IFIT2-depleted cells using small interfering RNA (siRNA). As shown in Figure 4a , the mRNAexpression levels of PKCz and PKCi were suppressed in the IFIT2-depleted cells 72 h after the transfection of the individual siRNAs. An antibody capable of distinguishing between PKCz and PKCi isoforms was not available; therefore, the siRNA-mediated knockdown of PKCz or PKCi was confirmed by western blot analysis of phosphorylated PKCz/i in the IFIT2-depleted cells. Additionally, the reduced phosphorylation of PKCz/i was accompanied by decreased phosphorylation of GSK3b at ser 9 and increased expression of E-cadherin in the IFIT2-depleted cells (Figure 4b 
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IFIT2 depletion promotes colonization in various organs
Upon determining that IFIT2 depletion promoted cell migration and cell invasion in OSCC cultures, we further investigated the metastatic activity of IFIT2-depleted cells in mice. Depletion of IFIT2 did not affect the proliferation or colony-forming activity of the cells on plastic dishes (Supplementary Figures S3a and b) . In addition, the sh-IFIT2-1, sh-IFIT2-2 and sh-control cells showed similar tumor growth rates in a xenograft model (Supplementary Figure S3c) . In contrast, upon sacrificing NOD/SCID mice 8 weeks after the tail vein injection of 5 Â 10 5 IFIT2-depleted or sh-control OSCC cells, we found that sh-control OSCC cells predominantly localized to tumor nodules in the lungs, whereas the IFIT2-depleted OSCC cells formed tumors in the lungs, as well as the thoracic, peritoneal and retroperitoneal cavities (summarized in Table 1 ). Although the injections of sh-control cells and IFIT2-depleted cells each gave rise to multiple nodules in the lungs of each mouse, mice that received sh-control cells had a greater number of lung colonies than mice injected with IFIT2-depleted cells ( Figure 5a ). As shown in Figure 5b , the tumors produced by the IFIT2-depleted cells in the heart, head and neck, peritoneum and retroperitoneal cavity of the mice were pathologically similar to the xenografted tumors (Supplementary Figure S3d) . Moreover, we discovered that some IFIT2-depleted tumor cells had invaded the lymph node, bone and muscle (Figure 5c ). These results suggested that IFIT2 depletion promotes tumor cell invasion and enhances the colonization of multiple organs by tumor cells. 
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sh-IFIT2-2 Figure 2 . IFIT2 depletion enhances cell migration and invasion. Sh-control, sh-IFIT2-1 and sh-IFIT2-2 CAL 27 cells were seeded into a 24-well plate and incubated overnight until a confluent monolayer formed. A wound was generated in the monolayer using a p200 tip, and the cells were incubated in serum-free medium for 24 h. (a) Photomicrographs were taken to illustrate wound healing. The white lines demarcate the wound edge. The relative migration was determined by measuring the remaining wound space and this information is summarized in the graph below. (b) Representative images of F-actin and E-cadherin immunostaining at the wound edge are shown. The bottom panels are magnified images of the areas within the white boxes in the panels above. (c) The invasiveness of sh-control, sh-IFIT2-1 and sh-IFIT2-2 cells was analyzed using Boyden chambers that were coated with a layer of matrix gel. All experiments were performed three times. *Po0.05, **Po0.01 and ***Po0.001 when compared with sh-control cells.
immunoreactivity) in OSCC tissues was associated with better patient survival. 22 To further examine the role of IFIT2 in the EMT of tumor tissues, we evaluated IFIT2 and E-cadherin gene expression in 19 OSCC patient-derived tumor specimens by Q-PCR and found a strong correlation between IFIT2 and E-cadherin mRNA expression (Figure 6a ; Pearson coefficient, r ¼ 0.787; Po0.0001). The positive association between IFIT2 and E-cadherin expression was also detected at the protein level by immunohistochemistry (Figure 6b ). In addition, the loss of IFIT2 and E-cadherin expression was observed along the invasive front (Figure 6c ). These data suggest that IFIT2 depletion may be associated with the metastatic activity of OSCC. Therefore, we further compared the IFIT2-expression levels between metastasisfree OSCC patients and OSCC patients with metastatic disease. IFIT2 expression was assessed by immunohistochemical analysis in tumor samples derived from 75 OSCC patients; 53 of these OSCC tumor samples had been used in our previous study. 22 The association between IFIT2 expression and several clinicopathological features are summarized in Table 2 . As shown in Table 2 and Figure 6d , the association between IFIT2 depletion and local-regional failure was marginally significant (P ¼ 0.05), whereas IFIT2 depletion exhibited a strong and significant association with distant metastasis (Po0.0001). However, a greater number of samples are required to further confirm these clinical features with IFIT2 depletion. Furthermore, distant metastasis may be a major cause of death in OSCC patients who have low IFIT2 levels, suggesting that distant metastasis may be a leading cause of death in OSCC patients with low IFIT2 levels ( Figure 6e ). We further used the Kaplan-Meier survival analysis to evaluate the correlation between IFIT2 expression and prognosis among the 75 OSCC patients. Consistent with our previous observation, 22 the 5-year survival rate of OSCC patients expressing reduced levels of IFIT2 was significantly lower than that of patients expressing greater levels of IFIT2 (Figure 7a ). The OSCC patients whose tumors were IFIT2-low experienced shorter disease-free survival and distant metastasis-free survival than those whose tumors were IFIT2-high (Figures 7b and c) . On univariate analysis, IFIT2 expression (cut off value was 50%, P ¼ 0.003), lymph-vascular invasion (P ¼ 0.05), and lymph node metastasis (cut off value was lymph node ¼ 1, P ¼ 0.05) were significantly associated with disease-free survival in OSCC patients. Furthermore, multivariate analyses revealed that IFIT2 expression is an independent 
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prognostic factor with respect to OSCC disease-free survival (P ¼ 0.000704; relative risk ¼ 4.348; 95% confidence interval ¼ 1.948-9.706). Taken together, these findings indicate that the loss of IFIT2 expression enhances the distant metastatic activity of OSCC cells and reduces the patient survival rate. More importantly, IFIT2 may serve as a valuable prognostic predictor of OSCC metastasis.
DISCUSSION
We recently reported that OSCC patients that exhibit high tumor IFIT2 expression have significantly improved post-surgery survival than those with low tumor IFIT2 expression. 22 IFIT2 depletion enhances the migration of cultured OSCC cells. 22 Here we have demonstrated that the activation of aPKC signaling is involved in the migration and EMT of IFIT2-depleted cells. We also found that, upon tail vein injection into mice, IFIT2-depleted cells colonized the thoracic, peritoneal and retroperitoneal cavities, whereas shcontrol cells predominantly colonized the lungs. In OSCC patients, we found an inverse association between IFIT2 expression and the distant metastatic rate and mortality. In addition, our results indicate a strong association between IFIT2 and E-cadherin expression in tumor samples collected from OSCC patients. These results demonstrate that IFIT2 depletion is associated with the malignant progression of OSCC and that IFIT2 may serve as a prognostic marker for OSCC patients with distant metastases.
Although IFIT2 has been identified as a member of the interferon-stimulated gene family of proteins, 19 knowledge of its role in cell migration is limited. 22 In the present study, we generated OSCC cell lines that stably expressed IFIT2-targeting short hairpin RNA (shRNA) to demonstrate that IFIT2 depletion promotes migration, invasion, and EMT. Numerous signaling pathways and transcription factors have been shown to orchestrate EMT and cell migration. 27 Our experiments uncovered an increase in the levels of the active forms of PKCz/i (phosphorylated PKCz/i), CDC42 (GTP-bound), and GSK3b (phosphorylated at Ser 9 ). Active CDC42-GTP is a positive regulator of aPKC, 28 and Ser 9 of GSK3b is phosphorylated by PKCz/i. 25 The results indicated that IFIT2 depletion induces activation of the aPKC signaling pathway. The involvement of aPKC activation in the EMT, migration and invasion of IFIT2-depleted cells was further supported by experiments in which siRNA was used to silence PKCz or PKCi. The reduction of phosphorylated PKCz or PKCi in IFIT2-depleted cells attenuated the enhanced EMT, migration and invasion of IFIT2-depleted cells.
The exact mechanism by which IFIT2 depletion activates the aPKC signaling pathway remains to be elucidated. Several studies, including ours, 22 have demonstrated the direct interaction of IFIT2 with cytoskeletal proteins, such as b-tubulin and cytokeratins. In the present study, we observed changes in the organization of F-actin and decreased cytokeratin 18 protein expression in IFIT2-depleted cells. As depletion of IFIT2 results in disorganization of the cytoskeleton, we suspect that IFIT2 may have a role in maintaining cell morphology and/or polarity. The activation of aPKC is independent of diacylglycerol and Ca 2 þ , but dependent on an allosteric interaction with the PAR6-CDC42 complex. 29 CDC42, a member of Rho GTPase family, functions in conjunction with the aPKC-PAR6-PAR3 complex to control centrosome polarization and microtubule reorganization. 30 The aPKC-PAR6-PAR3 complex has been shown to greatly contribute to the establishment of cell polarity in a variety of eukaryotic cell types. 25, 31, 32 The activation of the CDC42 and aPKC pathways in IFIT2-depleted cells is likely a cellular response to cytoskeletal disruption that occurs in cells with low IFIT2 levels. These results also support the hypothesis that IFIT2 participates in governing cytoskeletal dynamics and cell polarity.
A variety of kinases, [33] [34] [35] including aPKC, 31 inactivate GSK3b via phosphorylating Ser 9 . Inactivation of GSK3b usually results in the overexpression of oncogenic transcription factors, such as activator protein 1, nuclear factor kappa B, c-Myc, Snail, b-catenin and cAMP response element-binding. 36 These transcription factors are well-known regulators of EMT. 37, 38 Furthermore, GSK3b inactivation has been reported in most cancers of epithelial origin, including those of the breast and skin, as well as in cancers of the oral cavity. 39 In this study, we discovered an increase in the expression of ZEB1, an E-cadherin suppressor, 40 in the IFIT2-depleted cells. In addition, the silencing of PKCz or PKCi reduced the expression of ZEB1 and restored E-cadherin expression. As E-cadherin expression is thought to maintain the epithelial phenotype, 41 loss of E-cadherin is commonly observed in EMT and at the invasive front of cancers. 17 ,42 E-cadherin expression can be induced by GSK3b inhibition. 43 Therefore, we suggest that aPKC signaling, which is activated by IFIT2 depletion, is likely to activate ZEB1 expression and subsequently suppress E-cadherin expression. However, further experiments are required to confirm this possibility.
Tumor progression toward metastatic disease can be simplified into an ordered sequence of local invasion, intravasation, survival in the circulation, extravasation and colonization. 15 We designed an experiment to model cancer cells that have escaped from the primary tumor and then assessed the effect of IFIT2 on metastatic activity. Following tail vein injection into mice, IFIT2-depleted cells formed tumors in the head, neck, thoracic cavity, peritoneal cavity and retroperitoneal cavity. We also discovered that the IFIT2-deleted cells could invade the lymph node, bone and muscle, whereas the sh-control cells predominantly formed tumors in the lungs. These results strengthen the notion that IFIT2-depleted cells effectively extravasate through the vascular and lymphatic vessels, thereby enhancing the metastatic tropism of OSCC cells to multiple organs in mice. Recent studies have demonstrated that the molecular characteristics of both the target tissue and the cancer cells cooperate to influence the organotropism of Control  sh-IFIT2-1  sh-IFIT2-2   #1  #2  #3  #4  #5  #6  #7  #1  #2  #3  #4  #5  #6  #7  #1  #2  #3  #4  #5  #6 Head and neck
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IFIT2-aPKC regulates EMT in oral cancer cells KC Lai et al metastasis observed for many tumors. 44, 45 Metastatic tropism indicates the adoption of distinct adaptive programs in both the organ in which the metastatic colonization and outgrowth occurs as well as the tissue from which the metastatic cells originated. 46 OSCC often metastasizes to lung, bone and liver. 47 However, the molecular and pathways of organ-specific OSCC metastasis remain largely unknown. Further studies are required to determine whether IFIT2 participates in the organotropism of OSCC metastasis. Consistent with our previous clinical observations, 22 low IFIT2 expression enhances distant metastasis, which is a major cause of death in OSCC patients. Therefore, IFIT2 may potentially serve as a valuable biomarker for metastasis in patients with OSCC.
In summary, the present study suggests that EMT and the migratory/invasive phenotypes of IFIT2-depleted cells are aPKCdependent events. aPKC has been reported to be an important regulator of cytoskeletal architecture, cell migration and invasion. 25, 30 These results provide new insight into the mechanism by which aPKC promotes the migratory and invasive phenotypes of IFIT2-depleted OSCC cells. IFIT2 depletion has been shown to increase metastatic activity in animal models, and low expression of IFIT2 in metastatic OSCC patients correlates with high mortality; thus, IFIT2 may prove a useful biomarker to evaluate OSCC progression.
MATERIALS AND METHODS
Reagents, cell culture and lentiviral transduction
The CAL 27 human oral cancer cell line was cultured as previously described. 48 shRNA sequences specifically targeting human IFIT2 were synthesized and inserted into the GIPZ lentiviral vector (Open Biosystems, Huntsville, AL, USA). The sequence of the IFIT2 shRNA was the following: 5 0 -TGCTGTTGACAGTGAGCGCGCCAAATCCTTCATGTAATATTAGTG AAGCCACAGATGTAATATTACATGAAGGATTTGGCTTGCCTACTGCCTCGGA-3 0 . Lentiviral production was performed as described 49 and used to infect CAL 27 cells. IFIT2 is highly abundant in CAL 27 cells and its expression in the cells transfected with lentiviral IFIT2 shRNA is relatively heterogeneous.
To ensure the consistency of our experiments, puromycin-resistant colonies were selected to establish stable IFIT2-depleted cells, which were then maintained in the presence of 1 mg/ml puromycin (Sigma, St Louis, MO, USA). Gö 6976, Gö 6983 and the myristoylated PKCz pseudosubstrate were obtained from Calbiochem-Merck (Darmstadt, Germany).
Wound-healing assay
Cell migration was evaluated using an in vitro wound-healing assay. 22 In brief, the monolayer of cells was 'wounded' using a p200 micropipette tip and then incubated in serum-free DMEM medium (Invitrogen, Carlsbad, CA, USA) for 24 h in a tissue culture incubator. The wounded area was photographed at 0 h and 24 h and then assessed using Image Pro-Plus software (Media Cybernetics Inc., Bethesda, MD, USA). OSCC patients were divided into two subgroups based on IFIT2 immunoactivity: IFIT2 X50% and IFIT2 o50%, which represent patients whose tumors contained X50% IFIT2-positive cells and patients whose tumors contained o50% IFIT2-positive cells. The bars in the graph indicate the metastasis rate of OSCC patients expressing high or low IFIT2 levels. (e) A pie chart was generated for each OSCC patient subgroup (IFIT2 X50% and IFIT2 o50%) and indicates patient survival as well as the distribution of various metastatic states present in those patients who are deceased.
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Rhodamine-conjugated phalloidin staining and confocal microscopy
Cell monolayers were fixed with 4% paraformaldehyde in phosphatebuffered saline and stained with Rhodamine-conjugated phalloidin (Molecular Probe, Eugene, OR, USA), as previously described. 50 The confocal images were captured using an LSM510 META microscope (Carl Zeiss, Jena, Germany).
Quantitative real-time PCR Q-PCR was used to quantify the mRNA expression of the genes of interest. 51 In brief, Q-PCR was performed using the LightCycler 480 system (Roche Diagnostics, Pleasanton, CA, USA). The final 20 ml volume of each sample contained 5 ml of cDNA, 5 ml of SYBR green I master mix (Roche Diagnostics), and 200 nM of the appropriate primers. The relative differences in the mRNA-expression levels of the cells were expressed using cycle threshold (Ct) values. The expression of beta-2-microglobulin (b2M) was used to normalize the Q-PCR values, and each of the primers used is listed in supplementary table S1.
Transwell invasion assay
The modified Boyden chamber system 52 was used to evaluate the effects of altered IFIT2 expression on cellular invasion. Briefly, 2 Â 10 4 cells were suspended in 100 ml of FBS-free medium and seeded in the upper chamber of a transwell plate onto a membrane with 8-mm pores (Corning-Costar, Corning, NY, USA) that had been pre-coated with Matrigel (BD-Biosciences, Palo Alto, CA, USA). The lower chamber was filled with medium containing 10% FBS. After incubating for 24 h, the cells on the top side of the upper transwell membrane were removed using Q-tips (Chin Mee Inc., Kaohsiung, Taiwan). The cells trapped on the bottom side of the membrane were fixed and stained with 4,6-diamidino-2-phenylindole (Invitrogen) for 10 min. Fluorescence microscopy was used to count cells from eight different fields on each membrane, and these counts were averaged.
Western blot analysis
Western blotting was performed as previously described. 22 The relative expression level of each protein was determined using NIH Image J analysis software (Rockville, MD, USA). A polyclonal antibody raised against IFIT2 was generated (IgMedica Biotechnology Co., Taipei, Taiwan) using a synthetic peptide containing residues 403-426 of the human IFIT2 protein. 22 Commercially available antibodies were purchased from the following vendors: anti-E-cadherin and anti-N-cadherin were from BD Biosciences; anti-cytokeratin . Low IFIT2 expression correlates with poor prognosis in OSCC patients. The overall survival (a), disease-free survival (b), and distant metastasis-free survival (c) were analyzed in 75 OSCC patients using Kaplan-Meier plots.
18 was from Santa Cruz (Santa Cruz, CA, USA); anti-vimentin and anti-bactin were from Abcam (Cambridge, UK); the anti-phospho PKC sampler kit was from Cell Signaling (Danvers, MA, USA); anti-fibronectin, anti-CDC42 and anti-GSK3b were from GeneTex (Irvine, CA, USA). Rac and CDC42 activity was assessed using the RhoA/Rac1/CDC42 activation assay combo kit (Cell Biolabs, San Diego, CA, USA) according to the manufacturer's instructions.
Immunofluorescence staining
The cells were grown on glass coverslips, fixed with ice-cold methanol for 20 min at À 20 1C. After washing with phosphate-buffered saline, the cells were then incubated with an antibody against E-cadherin (1:100 dilution) in 1 Â TBBS buffer (20 mM Tris, 500 mM NaCl, pH 7.5, and 0.1% (v/v) Tween 20) containing 3% (w/v) bovine albumin for 1 h at 37 1C. The coverslips were then washed three times with phosphate-buffered saline and further incubated with Rhodamine-coupled secondary antibodies (Molecular Probes).
siRNA transfection CAL 27 cells were plated at a density of 2 Â 10 5 cells per 60-mm dish 1 day prior to transfection. The siRNA was transfected into the cells using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. The siRNA sequences used to target PKCz and PKCi mRNA were 5 0 -GAGGAAGUGAGAGACAUGUGUTT-3 0 and 5 0 -UCCUUCAAGUCAU GAGAGUTT-3 0 , respectively. The double-stranded RNA 5 0 -CGUACGCG GAAUACUUCGATT-3 0 , which targeted the luciferase gene, was used as a negative control.
Tumor colonization in mice
To compare the colonization of parental CAL 27 cells and CAL 27 cells depleted of IFIT2, we injected 5 Â 10 5 cells into the tail veins of 6-to 9-week-old NOD/SCID mice. After 8 weeks, the animals were euthanized, and various organs from the thoracic, peritoneal and retroperitoneal cavities were removed, rinsed, fixed and subjected to pathological examination. The number of pulmonary tumor colonies was determined by using a dissecting microscope.
Immunohistochemical staining
Tissue samples were retrieved from the Mackay Memorial Hospital in Taipei, Taiwan, with the approval of the hospital's institutional review board. In this study, tissue arrays containing 75 primary-OSCC specimens were stained with antibodies raised against IFIT2 (1:300) or E-cadherin (1:250) and then subjected to immunohistochemical examination, as described in our previous study. 22 
Statistical analysis
The student's t-test was used to determine the statistical significance of the observed differences between the experimental groups. *Po0.05, **Po0.01 and ***Po0.001. The correlation between IFIT2 expression and various clinical parameters was analyzed using the w 2 test. The KaplanMeier method with log-rank test was used to estimate overall survival, disease-free survival and distant metastasis-free survival. Univariate association between individual clinical feature and disease-free survival was determined with the log-rank test, while multivariate analysis was carried out using the Cox proportional hazards model. Variables with Po0.1 in the univariate analysis were included in the multivariate analysis (SPSS software 17.0, SPSS Inc., Chicago, IL, USA).
